The company that makes the abortion pill mifepristone urged the Supreme Court to throw out a challenge to loosened regulations that made the pill more accessible to women.
The case, which will be heard later this month, is the Supreme Court’s most important abortion-related case since its decision in June 2022 in Dobbs v. Jackson Women’s Health Organization, which overturned Roe v. Wade (1973) and found that there was no right to abortion in the U.S. Constitution.
